Aptevo Therapeutics Inc. Annual Operating Lease, Payments in USD from 2019 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Aptevo Therapeutics Inc. annual/quarterly Operating Lease, Payments history and growth rate from 2019 to 2024.
  • Aptevo Therapeutics Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $344K, a 199% increase year-over-year.
  • Aptevo Therapeutics Inc. annual Operating Lease, Payments for 2024 was $1.38M, a 20% increase from 2023.
  • Aptevo Therapeutics Inc. annual Operating Lease, Payments for 2023 was $1.15M, a 28.2% increase from 2022.
  • Aptevo Therapeutics Inc. annual Operating Lease, Payments for 2022 was $895K, a 35.5% decline from 2021.
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $1.38M +$229K +20% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-14
2023 $1.15M +$252K +28.2% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-14
2022 $895K -$492K -35.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-05
2021 $1.39M -$93K -6.28% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 $1.48M -$234K -13.7% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-24
2019 $1.71M Jan 1, 2019 Dec 31, 2019 10-K 2021-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.